OSIRIS Trademark

Trademark Overview

On Thursday, August 20, 1998, a trademark application was filed for OSIRIS with the United States Patent and Trademark Office. The USPTO has given the OSIRIS trademark a serial number of 75539594. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, February 17, 2021. This trademark is owned by Osiris Therapeutics, Inc.. The OSIRIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon

Research and development for pharmaceutical products, namely, screening and genetic engineering of cell therapy products
osiris

General Information

Serial Number75539594
Word MarkOSIRIS
Filing DateThursday, August 20, 1998
Status800 - REGISTERED AND RENEWED
Status DateWednesday, February 17, 2021
Registration Number2396854
Registration DateTuesday, October 24, 2000
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 1, 2000

Trademark Statements

Goods and ServicesCells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon
Goods and ServicesResearch and development for pharmaceutical products, namely, screening and genetic engineering of cell therapy products

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 28, 1998
Primary Code005
First Use Anywhere DateWednesday, March 31, 1993
First Use In Commerce DateSunday, November 30, 1997
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 28, 1998
Primary Code042
First Use Anywhere DateWednesday, March 31, 1993
First Use In Commerce DateSunday, November 30, 1997

Trademark Owner History

Party NameOsiris Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046
Party NameOsiris Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 212313043
Party NameOsiris Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 212313043

Trademark Events

Event DateEvent Description
Wednesday, February 17, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, February 17, 2021REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Wednesday, February 17, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, February 7, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, January 16, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Saturday, January 16, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, October 25, 2020TEAS SECTION 8 & 9 RECEIVED
Thursday, October 24, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 18, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 18, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 18, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 18, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 7, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 7, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 28, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, October 28, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 27, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 21, 2010TEAS SECTION 8 & 9 RECEIVED
Monday, January 14, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 14, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 11, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 11, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 28, 2006REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 22, 2006ASSIGNED TO PARALEGAL
Friday, July 21, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, July 21, 2006TEAS SECTION 8 & 15 RECEIVED
Thursday, January 5, 2006CASE FILE IN TICRS
Tuesday, October 24, 2000REGISTERED-PRINCIPAL REGISTER
Tuesday, August 1, 2000PUBLISHED FOR OPPOSITION
Friday, June 30, 2000NOTICE OF PUBLICATION
Tuesday, April 4, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 27, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 29, 1999NON-FINAL ACTION MAILED
Thursday, June 3, 1999PETITION TO DIRECTOR - GRANTED
Wednesday, May 19, 1999PETITION TO DIRECTOR RECEIVED
Tuesday, April 6, 1999ASSIGNED TO EXAMINER

Related Keywords

osiris products tissue namely therapy pharmaceutical development screening genetic cell research